Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Plasma Cell Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01670812
What this trial is testing

Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
The First Affiliated Hospital with Nanjing Medical University 100
Testing effectiveness (Phase 2)Study completedNCT02566265
What this trial is testing

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients

Who this might be right for
InfluenzaMultiple MyelomaWaldenstrom's Macroglobulinemia+2 more
Yale University 122
Early research (Phase 1)Not Yet RecruitingNCT07759102
What this trial is testing

Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
University of California, Davis 20
Testing effectiveness (Phase 2)Study completedNCT04099901
What this trial is testing

Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial

Who this might be right for
Multiple Myeloma
Radboud University Medical Center 88
Post-approval studies (Phase 4)Looking for participantsNCT06409702
What this trial is testing

Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

Who this might be right for
Newly DiagnosedHigh RiskMRD+1 more
The First Affiliated Hospital of Soochow University 59
Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Ended earlyNCT00681044
What this trial is testing

HD Melphalan and SCT in Patients With IGDD or LCDD

Who this might be right for
Multiple Myeloma
Boston Medical Center 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03289299
What this trial is testing

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant

Who this might be right for
Smoldering Multiple Myeloma
International Myeloma Foundation 87
Testing effectiveness (Phase 2)Study completedNCT01270932
What this trial is testing

Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients

Who this might be right for
Renal FailureMultiple Myeloma
University Health Network, Toronto 28
Testing effectiveness (Phase 2)Looking for participantsNCT06207799
What this trial is testing

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

Who this might be right for
Multiple MyelomaPost-transplant MRD-guided Maintenance TherapyPre-transplant Purging
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01008462
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more
Fred Hutchinson Cancer Center 16
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01131169
What this trial is testing

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT00602706
What this trial is testing

Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 76
Testing effectiveness (Phase 2)Study completedNCT00642395
What this trial is testing

Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT)

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 61
Early research (Phase 1)Study completedNCT00288028
What this trial is testing

Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT00004107
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia

Who this might be right for
LeukemiaLymphoma
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 18
Testing effectiveness (Phase 2)Study completedNCT02937571
What this trial is testing

High Dose Carfilzomib for Newly Diagnosed Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 29
Large-scale testing (Phase 3)UnknownNCT00028886
What this trial is testing

Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Commissie Voor Klinisch Toegepast Onderzoek 450
Testing effectiveness (Phase 2)Study completedNCT01441973
What this trial is testing

Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Bristol-Myers Squibb 41
Next Page